Tomaras, G. D., Montefiori, D., Cohen, K. W., Heptinstall, J., De Rosa, S. C., Sawant, S., … Frahm, N. (2018). Tetravalent Janssen Mosaic Ad26/Protein HIV Vaccine Shows Increased Clade C Env-specific CD4+T-cell and Antibody Responses Versus Trivalent Vaccine. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 34, pp. 187–187). Madrid, SPAIN: MARY ANN LIEBERT, INC.

Tomaras, Georgia D., David Montefiori, Kristen W. Cohen, Jack Heptinstall, Stephen C. De Rosa, Sheetal Sawant, Lindsey R. Baden, et al. “Tetravalent Janssen Mosaic Ad26/Protein HIV Vaccine Shows Increased Clade C Env-specific CD4+T-cell and Antibody Responses Versus Trivalent Vaccine.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 34:187–187. MARY ANN LIEBERT, INC, 2018.

Tomaras GD, Montefiori D, Cohen KW, Heptinstall J, De Rosa SC, Sawant S, et al. Tetravalent Janssen Mosaic Ad26/Protein HIV Vaccine Shows Increased Clade C Env-specific CD4+T-cell and Antibody Responses Versus Trivalent Vaccine. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2018. p. 187–187.

Tomaras, Georgia D., et al. “Tetravalent Janssen Mosaic Ad26/Protein HIV Vaccine Shows Increased Clade C Env-specific CD4+T-cell and Antibody Responses Versus Trivalent Vaccine.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 34, MARY ANN LIEBERT, INC, 2018, pp. 187–187.

Tomaras GD, Montefiori D, Cohen KW, Heptinstall J, De Rosa SC, Sawant S, Baden LR, Goepfert PA, Keefer MC, Edupuganti S, Stieh D, Hendriks J, Moodie Z, Corey L, Kublin JG, McElrath MJ, Nijs S, Frahm N. Tetravalent Janssen Mosaic Ad26/Protein HIV Vaccine Shows Increased Clade C Env-specific CD4+T-cell and Antibody Responses Versus Trivalent Vaccine. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2018. p. 187–187.